← Open Payments lookup

MARY ANNE CARDENAS: Open Payments

NPI 1073223368 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,212 in 94 payments from 19 companies in 2025. Trend: 2023 $1,149 · 2024 $3,541 · 2025 $2,212

Food & beverage: $2,212
CompanyPaymentsAmount
ABBVIE INC.47$1,133
Neurocrine BioSciences, Inc.6$219
Takeda Pharmaceuticals U.S.A., Inc.6$150
ARGENX US, INC.9$137
UCB, Inc.4$130
Teva Pharmaceuticals USA, Inc.3$66
Janssen Biotech, Inc.3$56
Genentech USA, Inc.3$50
Otsuka America Pharmaceutical, Inc.2$35
GENZYME CORPORATION1$32

Products named: BOTOX, QULIPTA, UBRELVY, INGREZZA, HYQVIA, Rystiggo, VYVGART HYTRULO, AUSTEDO XR.

Industry payments across NV — which companies pay providers there.